Blab AI
Cosmos Health to Deploy AI-Powered Call Center for Subsidiary CosmoFarm
On June 23 2026, Cosmos Health Inc. (NASDAQ:COSM) announced a new partnership to install an artificial‑intelligence‑powered call center for its wholly owned pharmaceutical distribution arm, Cos MoFarm S.A. The system, described in the company’s press release, will handle inbound and outbound customer calls, support order intake, and automate routine support functions.
The platform will feature a multilingual voice assistant, intelligent call routing, outbound campaign automation, seamless integration with Cos MoFarm’s back‑end systems, and real‑time reporting dashboards. Its primary aim is to streamline customer interactions and cut the manual handling of high‑volume transactions.
Cos MoFarm has recently posted record quarterly revenue and continues to expand its pharmacy network. The surge in transaction volume has made scalable, intelligent customer engagement a top priority. By automating routine interactions, the AI call center is expected to boost process efficiency, lower operating costs, increase responsiveness, and reduce errors.
This initiative is part of Cosmos Health’s broader AI strategy, unveiled in April 2026. The company has been rolling out AI solutions across front‑end operations—such as order management and customer relationship handling—and back‑end operations, including warehouse optimization, inventory management, and supply‑chain processes. Cosmos Health estimates that AI‑driven optimization could cut specific operating expenses by up to 30% in certain areas.
Greg Siokas, Cosmos Health’s chief executive officer, said: "Deploying an AI‑powered call center to support order intake and customer communications is a natural next step in our AI strategy, using technology to drive process optimization, cost efficiencies, and an improved customer experience. This is expected to deliver meaningful benefits across our operations, particularly within Cos MoFarm, where record growth and a rapidly expanding customer base make intelligent automation increasingly valuable."
Cosmos Health is a diversified, vertically integrated global healthcare group founded in 2009. Its portfolio includes proprietary pharmaceutical and nutraceutical brands such as Sky Premium Life®, Mediterranation®, bio‑bebe®, C‑Sept®, and C‑Scrub®. The company manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices through its subsidiary Cana Laboratories S.A., which holds European Good Manufacturing Practice certification and is approved by the European Medicines Agency. Cosmos Health also distributes branded generics and over‑the‑counter medications to retail pharmacies and wholesale distributors in Greece and the United Kingdom. In addition, the company has entered the telehealth market through the acquisition of ZipDoctor, Inc. in Texas.
The press release notes that the AI call center is part of Cosmos Health’s ongoing integration of AI across its operations. The company’s forward‑looking statements, as disclosed in the release, highlight risks such as financing, regulatory changes, geopolitical events, and the effectiveness of its digital asset strategies.
At present, Cosmos Health has not announced a specific launch date for the AI call center. The company’s focus remains on deploying the platform to support Cos MoFarm’s growing customer base and to achieve the cost‑efficiency gains outlined in its AI strategy.
The announcement underscores Cosmos Health’s continued investment in AI technologies to improve operational efficiency and customer experience within its pharmaceutical distribution business.
The platform will feature a multilingual voice assistant, intelligent call routing, outbound campaign automation, seamless integration with Cos MoFarm’s back‑end systems, and real‑time reporting dashboards. Its primary aim is to streamline customer interactions and cut the manual handling of high‑volume transactions.
Cos MoFarm has recently posted record quarterly revenue and continues to expand its pharmacy network. The surge in transaction volume has made scalable, intelligent customer engagement a top priority. By automating routine interactions, the AI call center is expected to boost process efficiency, lower operating costs, increase responsiveness, and reduce errors.
This initiative is part of Cosmos Health’s broader AI strategy, unveiled in April 2026. The company has been rolling out AI solutions across front‑end operations—such as order management and customer relationship handling—and back‑end operations, including warehouse optimization, inventory management, and supply‑chain processes. Cosmos Health estimates that AI‑driven optimization could cut specific operating expenses by up to 30% in certain areas.
Greg Siokas, Cosmos Health’s chief executive officer, said: "Deploying an AI‑powered call center to support order intake and customer communications is a natural next step in our AI strategy, using technology to drive process optimization, cost efficiencies, and an improved customer experience. This is expected to deliver meaningful benefits across our operations, particularly within Cos MoFarm, where record growth and a rapidly expanding customer base make intelligent automation increasingly valuable."
Cosmos Health is a diversified, vertically integrated global healthcare group founded in 2009. Its portfolio includes proprietary pharmaceutical and nutraceutical brands such as Sky Premium Life®, Mediterranation®, bio‑bebe®, C‑Sept®, and C‑Scrub®. The company manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices through its subsidiary Cana Laboratories S.A., which holds European Good Manufacturing Practice certification and is approved by the European Medicines Agency. Cosmos Health also distributes branded generics and over‑the‑counter medications to retail pharmacies and wholesale distributors in Greece and the United Kingdom. In addition, the company has entered the telehealth market through the acquisition of ZipDoctor, Inc. in Texas.
The press release notes that the AI call center is part of Cosmos Health’s ongoing integration of AI across its operations. The company’s forward‑looking statements, as disclosed in the release, highlight risks such as financing, regulatory changes, geopolitical events, and the effectiveness of its digital asset strategies.
At present, Cosmos Health has not announced a specific launch date for the AI call center. The company’s focus remains on deploying the platform to support Cos MoFarm’s growing customer base and to achieve the cost‑efficiency gains outlined in its AI strategy.
The announcement underscores Cosmos Health’s continued investment in AI technologies to improve operational efficiency and customer experience within its pharmaceutical distribution business.
